a year ago
ARWR
AnalystsMadhu KumarMadhu Kumar's Stock Forecasts
AnalystsMadhu Kumar
Analyst Ranking
Top 2%
#50 out of 4174 analysts
Average Return
+26.5%
Win Rate
59%46 out of 78
Risk vs Reward
Poor
Good
Madhu Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Catalyst Biosciences IncCBIO | +450.00% | $4.38 | $24.09 | 2017-06-11 - 2018-06-12 | Strong Buy |
Scholar Rock Holding CorpSRRK | +331.26% | $14.97 | $64.56 | 2020-03-11 - 2021-03-12 | Buy |
Arbutus Biopharma CorpABUS | +309.92% | $1.21 | $4.96 | 2020-03-26 - 2020-07-24 | Buy |
Clementia Pharmaceuticals IncCMTA | +211.47% | $8.46 | $26.35 | 2018-08-14 - 2019-04-17 | Strong Buy |
Arcturus Therapeutics Holdings IncARCT | +206.96% | $13.80 | $42.36 | 2020-02-10 - 2020-12-29 | Buy |
Madhu Kumar Analyst Color
Get additional color on Madhu Kumar's coverage of popular stocks
a year ago
MGTA
Madhu Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Fulcrum Therapeutics IncFULC | 2 | Strong Buy | $17.00 | +36.99% | Maintains | 19 days ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $56.00 | +24.89% | Maintains | 21 days ago |
Syndax Pharmaceuticals IncSNDX | 4 | Strong Buy | $39.00 | +47.00% | Maintains | 2 months ago |
Iovance Biotherapeutics IncIOVA | 5 | Hold | $6.00 | -26.83% | Downgrades | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 5 | Strong Buy | $190.00 | +24.08% | Upgrades | 2 months ago |
Reata Pharmaceuticals IncRETA | 4 | Strong Buy | $115.00 | +131.48% | Maintains | 2 months ago |
Arcturus Therapeutics Holdings IncARCT | 4 | Strong Sell | $14.00 | -34.09% | Maintains | 3 months ago |
Dynavax Technologies CorpDVAX | 2 | Strong Buy | $21.00 | +80.57% | Maintains | 3 months ago |
Cincor Pharma IncCINC | 1 | Strong Buy | $67.00 | +129.30% | Initiates Coverage On | 3 months ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $28.00 | -18.63% | Maintains | 5 months ago |
Homology Medicines IncFIXX | 1 | Buy | $9.00 | +462.50% | Maintains | 5 months ago |
Krystal Biotech IncKRYS | 2 | Hold | $74.00 | -7.44% | Downgrades | 5 months ago |
Edgewise Therapeutics IncEWTX | 2 | Strong Sell | $5.00 | -51.41% | Downgrades | 5 months ago |
Magenta Therapeutics IncMGTA | 2 | Hold | $2.00 | +145.70% | Downgrades | 5 months ago |
Apellis Pharmaceuticals IncAPLS | 6 | Strong Buy | $102.00 | +84.75% | Maintains | 6 months ago |
Arrowhead Pharmaceuticals IncARWR | 6 | Strong Buy | $65.00 | +93.97% | Maintains | 6 months ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Strong Buy | $144.00 | +30.61% | Maintains | 6 months ago |
Myovant Sciences LtdMYOV | 1 | Hold | $10.00 | -62.80% | Maintains | 6 months ago |
Tricida IncTCDAQ | 1 | Strong Buy | $25.00 | +23,048.15% | Initiates Coverage On | 10 months ago |
Alector IncALEC | 1 | Strong Sell | $9.00 | -6.25% | Initiates Coverage On | 10 months ago |
Passage Bio IncPASG | 1 | Hold | $6.00 | N/A | Downgrades | a year ago |
Design Therapeutics IncDSGN | 1 | Strong Sell | $10.00 | N/A | Initiates Coverage On | a year ago |
Arvinas IncARVN | 1 | Strong Buy | $157.00 | N/A | Initiates Coverage On | a year ago |
Applied Therapeutics IncAPLT | 1 | Strong Sell | $10.00 | N/A | Downgrades | a year ago |
Dicerna Pharmaceuticals IncDRNA | 5 | Hold | $25.00 | N/A | Downgrades | a year ago |
Intellia Therapeutics IncNTLA | 5 | Hold | $85.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 3 | Strong Sell | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Cellectis SaCLLS | 2 | Buy | $39.00 | N/A | Upgrades | 2 years ago |
Gritstone Bio IncGRTS | 1 | Sell | $8.00 | N/A | Downgrades | 2 years ago |
Cellular Biomedicine Group IncCBMG | 2 | Hold | $19.00 | N/A | Downgrades | 2 years ago |
Uniqure NvQURE | 2 | Buy | $57.00 | N/A | Upgrades | 3 years ago |
Arbutus Biopharma CorpABUS | 8 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aprea Therapeutics IncAPRE | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Vir Biotechnology IncVIR | 1 | Sell | $20.00 | N/A | Maintains | 3 years ago |
Pieris Pharmaceuticals IncPIRS | 1 | Buy | $5.00 | N/A | Upgrades | 3 years ago |
Scholar Rock Holding CorpSRRK | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Leap Therapeutics IncLPTX | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Spark Therapeutics IncONCE | 1 | Strong Buy | $71.00 | N/A | Upgrades | 4 years ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $6.00 | N/A | Maintains | 4 years ago |
Assembly Biosciences IncASMB | 3 | Strong Buy | $42.00 | N/A | Upgrades | 4 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $55.00 | N/A | Maintains | 4 years ago |
Clementia Pharmaceuticals IncCMTA | 2 | Strong Buy | $16.00 | N/A | Maintains | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $230.00 | N/A | Maintains | 4 years ago |
Regulus Therapeutics IncRGLS | 3 | Hold | $0.50 | N/A | Maintains | 5 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Catalyst Biosciences IncCBIO | 2 | Strong Buy | $75.00 | N/A | Maintains | 5 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Akari Therapeutics PLCAKTX | 3 | Hold | $3.00 | N/A | Initiates Coverage On | 5 years ago |
Achillion Pharmaceuticals IncACHN | 1 | Hold | $3.50 | N/A | Initiates Coverage On | 5 years ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $21.50 | N/A | Reinstates | 5 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $23.50 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.